Back to News
Market Impact: 0.5

FactSet Research (FDS) Q4 Earnings Lag Estimates

FDSBYRN
Corporate EarningsAnalyst EstimatesCorporate Guidance & OutlookCompany FundamentalsInvestor Sentiment & Positioning

FactSet Research (FDS) reported Q4 earnings of $4.05 per share, missing the Zacks Consensus Estimate of $4.15 by 2.41%, though it represents a year-over-year increase from $3.74. Concurrently, the financial data firm's revenue reached $596.9 million, surpassing the consensus estimate by 0.73% and growing from $562.19 million in the prior year. Despite the revenue beat, FDS shares have significantly underperformed, losing approximately 30% year-to-date, and the company carries a Zacks Rank #4 (Sell) due to unfavorable estimate revisions, signaling potential continued market underperformance.

Analysis

FactSet (FDS) reported mixed Q4 fiscal 2025 results, characterized by a slight revenue beat but a notable earnings miss, exacerbating existing negative sentiment. Revenue for the quarter was $596.9 million, exceeding the Zacks Consensus Estimate by 0.73% and representing year-over-year growth from $562.19 million. However, this top-line resilience was overshadowed by adjusted earnings per share of $4.05, which missed the consensus of $4.15 by 2.41%. This marks the company's second consecutive quarterly EPS miss, signaling potential margin pressure or escalating costs despite continued revenue growth from the prior year's $3.74 EPS. The market has already priced in significant concerns, with FDS shares having lost approximately 30% year-to-date, in stark contrast to the S&P 500's 12.2% gain. Underscoring the bearish outlook, the stock carried an unfavorable estimate revision trend into the report and holds a Zacks Rank #4 (Sell), suggesting continued underperformance. The broader industry context provides an additional headwind, as the Business - Information Services sector ranks in the bottom 36% of over 250 Zacks-ranked industries.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo